These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38489996)

  • 1. Comment on: Frozen sections accurately predict the IASLC proposed grading system and prognosis in patients with invasive lung adenocarcinomas.
    Yu T; Zhou X; Li M
    Lung Cancer; 2024 Apr; 190():107534. PubMed ID: 38489996
    [No Abstract]   [Full Text] [Related]  

  • 2. Frozen sections accurately predict the IASLC proposed grading system and prognosis in patients with invasive lung adenocarcinomas.
    Fan J; Yao J; Si H; Xie H; Ge T; Ye W; Chen J; Yin Z; Zhuang F; Xu L; Su H; Zhao S; Xie X; Zhao D; Wu C; Zhu Y; Ren Y; Xu N; Chen C;
    Lung Cancer; 2023 Apr; 178():123-130. PubMed ID: 36822017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Simplified Version of the IASLC Grading System for Invasive Pulmonary Adenocarcinomas With Improved Prognosis Discrimination.
    Bossé Y; Gagné A; Althakfi WA; Orain M; Couture C; Trahan S; Pagé S; Joubert D; Fiset PO; Desmeules P; Joubert P
    Am J Surg Pathol; 2023 Jun; 47(6):686-693. PubMed ID: 37032554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The IASLC Proposed Grading System Accurately Predicts Prognosis and Mediastinal Nodal Metastasis in Patients With Clinical Stage I Lung Adenocarcinoma.
    Xu L; Su H; Hou L; Wang F; Xie H; She Y; Gao J; Zhao S; Dai C; Xie D; Zhu Y; Wu C; Zhao D; Chen C;
    Am J Surg Pathol; 2022 Dec; 46(12):1633-1641. PubMed ID: 36224092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The new IASLC grading system for invasive non-mucinous lung adenocarcinoma is a more useful indicator of patient survival compared with previous grading systems.
    Yanagawa N; Sugai M; Shikanai S; Sugimoto R; Osakabe M; Uesugi N; Saito H; Maemondo M; Sugai T
    J Surg Oncol; 2023 Jan; 127(1):174-182. PubMed ID: 36098331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation Study of New IASLC Histology Grading System in Stage I Non-Mucinous Adenocarcinoma Comparing With Minimally Invasive Adenocarcinoma.
    Woo W; Cha YJ; Kim BJ; Moon DH; Lee S
    Clin Lung Cancer; 2022 Nov; 23(7):e435-e442. PubMed ID: 35945128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognosis of resected invasive mucinous adenocarcinoma compared with the IASLC histologic grading system for invasive nonmucinous adenocarcinoma: Surgical database study in the TKIs era in Korea.
    Woo W; Yang YH; Cha YJ; Moon DH; Shim HS; Cho A; Kim BJ; Kim HE; Park BJ; Lee JG; Kim DJ; Paik HC; Lee S; Lee CY
    Thorac Cancer; 2022 Dec; 13(23):3310-3321. PubMed ID: 36345148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the novel International Association for the Study of Lung Cancer grading system and prognostic value of filigree micropapillary and discohesive growth pattern in invasive pulmonary adenocarcinoma.
    Zhang Y; Zhang Y; Hu Y; Zhang S; Zhu M; Hu B; Guo X; Lu J; Zhang Y
    Lung Cancer; 2023 Jan; 175():79-87. PubMed ID: 36481678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-grade tumor classified by new system is a prognostic predictor in resected lung adenocarcinoma.
    Yoshida C; Yokomise H; Ibuki E; Go T; Haba R; Kadota K
    Gen Thorac Cardiovasc Surg; 2022 May; 70(5):455-462. PubMed ID: 35050467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic value of histopathology in invasive lung adenocarcinoma: a comparative review of the main proposed grading systems.
    Lucà S; Zannini G; Morgillo F; Della Corte CM; Fiorelli A; Zito Marino F; Campione S; Vicidomini G; Guggino G; Ronchi A; Accardo M; Franco R
    Expert Rev Anticancer Ther; 2023 Mar; 23(3):265-277. PubMed ID: 36772823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of the IASLC grading system of lung adenocarcinoma: a systematic review and meta-analysis.
    Hegedűs F; Zombori-Tóth N; Kiss S; Lantos T; Zombori T
    Histopathology; 2024 Jul; 85(1):51-61. PubMed ID: 38485464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excellent Prognosis of Patients With Invasive Lung Adenocarcinomas During Surgery Misdiagnosed as Atypical Adenomatous Hyperplasia, Adenocarcinoma In Situ, or Minimally Invasive Adenocarcinoma by Frozen Section.
    Zhang Y; Deng C; Fu F; Ma Z; Wen Z; Ma X; Wang S; Li Y; Chen H
    Chest; 2021 Mar; 159(3):1265-1272. PubMed ID: 33197404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accuracy of the IASLC/ATS/ERS histological subtyping of stage I lung adenocarcinoma on intraoperative frozen sections.
    Trejo Bittar HE; Incharoen P; Althouse AD; Dacic S
    Mod Pathol; 2015 Aug; 28(8):1058-63. PubMed ID: 26022456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Updates on lung adenocarcinoma: invasive size, grading and STAS.
    Willner J; Narula N; Moreira AL
    Histopathology; 2024 Jan; 84(1):6-17. PubMed ID: 37872108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using frozen section to identify histological patterns in stage I lung adenocarcinoma of ≤ 3 cm: accuracy and interobserver agreement.
    Yeh YC; Nitadori J; Kadota K; Yoshizawa A; Rekhtman N; Moreira AL; Sima CS; Rusch VW; Adusumilli PS; Travis WD
    Histopathology; 2015 Jun; 66(7):922-38. PubMed ID: 24889415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic and predictive value of the newly proposed grading system of invasive pulmonary adenocarcinoma in Chinese patients: a retrospective multicohort study.
    Hou L; Wang T; Chen D; She Y; Deng J; Yang M; Zhang Y; Zhao M; Zhong Y; Ma M; Zhao G; Chen Y; Xie D; Zhu Y; Chen Q; Wu C; Chen C;
    Mod Pathol; 2022 Jun; 35(6):749-756. PubMed ID: 35013526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proposed novel grading system for stage I invasive lung adenocarcinoma and a comparison with the 2020 IASLC grading system.
    Wang S; Li Y; Sun X; Dong J; Liu L; Liu J; Chen R; Li F; Chen T; Li X; Xie G; Ying J; Guo Q; Mao Y; Yang L
    Thorac Cancer; 2024 Mar; 15(7):519-528. PubMed ID: 38273667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proposal of a revised International Association for the Study of Lung Cancer grading system in pulmonary non-mucinous adenocarcinoma: The importance of the lepidic proportion.
    Park BJ; Woo W; Cha YJ; Shim HS; Yang YH; Moon DH; Kim BJ; Kim HE; Kim DJ; Paik HC; Lee JG; Lee S; Lee CY
    Lung Cancer; 2023 Jan; 175():1-8. PubMed ID: 36436241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraoperatively measured tumor size and frozen section results should be considered jointly to predict the final pathology for lung adenocarcinoma.
    Zhu E; Xie H; Dai C; Zhang L; Huang Y; Dong Z; Guo J; Su H; Ren Y; Shi P; Fu R; Qin S; Wu C; Chen C
    Mod Pathol; 2018 Sep; 31(9):1391-1399. PubMed ID: 29752477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic impact of pattern-based grading system by the new IASLC/ATS/ERS classification in Asian patients with stage I lung adenocarcinoma.
    Zhao ZR; Xi SY; Li W; Situ DR; Chen KM; Yang H; Su XD; Lin YB; Long H
    Lung Cancer; 2015 Dec; 90(3):604-9. PubMed ID: 26547801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.